0 (0%) | 03-29 04:17 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 51.4 | 1-year : | 60.03 |
Resists | First : | 44 | Second : | 51.4 |
Pivot price | 42.29 | |||
Supports | First : | 41.69 | Second : | 40.27 |
MAs | MA(5) : | 42.13 | MA(20) : | 42.34 |
MA(100) : | 38.99 | MA(250) : | 40.53 | |
MACD | MACD : | 0.2 | Signal : | 0.3 |
%K %D | K(14,3) : | 39.1 | D(3) : | 29.5 |
RSI | RSI(14): 58.8 | |||
52-week | High : | 50.2 | Low : | 31.01 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ BAX ] has closed below upper band by 33.8%. Bollinger Bands are 16.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 43.19 - 43.39 | 43.39 - 43.58 |
Low: | 42.09 - 42.34 | 42.34 - 42.56 |
Close: | 42.34 - 42.74 | 42.74 - 43.1 |
Thu, 28 Mar 2024
Barrick Gold (TSE:ABX) Share Price Crosses Above 200 Day Moving Average of $21.71 - Defense World
Thu, 28 Mar 2024
Analysts Set Barrick Gold Co. (TSE:ABX) Target Price at C$28.81 - MarketBeat
Tue, 26 Mar 2024
CDC Offers Guidance for Abx Prophylaxis for Resistant Meningococcal Disease - Pharmacy Practice News
Fri, 22 Mar 2024
BARRICK GOLD CORPORATION Trade Ideas — TSX:ABX — TradingView - TradingView
Fri, 22 Mar 2024
Benchmark ABX subprime index hits new low -sources - Reuters
Fri, 22 Mar 2024
CDC Offers Guidance for Abx Prophylaxis for Resistant Meningococcal Disease - Infectious Disease Special Edition
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 508 (M) |
Shares Float | 505 (M) |
Held by Insiders | 0.3 (%) |
Held by Institutions | 92.7 (%) |
Shares Short | 8,130 (K) |
Shares Short P.Month | 7,480 (K) |
EPS | -0.16 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 16.54 |
Profit Margin | 17.9 % |
Operating Margin | 12 % |
Return on Assets (ttm) | 3.3 % |
Return on Equity (ttm) | -1 % |
Qtrly Rev. Growth | 3.7 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 29.16 |
EBITDA (p.s.) | 5.47 |
Qtrly Earnings Growth | 33.7 % |
Operating Cash Flow | 1,730 (M) |
Levered Free Cash Flow | 1,700 (M) |
PE Ratio | -284.94 |
PEG Ratio | 3.5 |
Price to Book value | 2.58 |
Price to Sales | 1.46 |
Price to Cash Flow | 12.54 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |